A Case of Massive Pulmonary Embolism in Systemic Lupus Erythematosus without Antiphospholipid Antibody.
10.4078/jrd.2015.22.2.106
- Author:
Jae Hyun JUNG
1
;
Min Gu LEE
;
Ju Sung SIM
;
Tae Hyun KIM
;
Hong Kwon OH
;
Jong Dae JI
;
Young Ho LEE
Author Information
1. Division of Rheumatology, Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea. lyhcgh@korea.ac.kr
- Publication Type:Case Report
- Keywords:
Pulmonary embolism;
Systemic lupus erythematosus;
Antiphospholipid antibodies
- MeSH:
Antibodies, Antiphospholipid*;
Chest Pain;
Dyspnea;
Female;
Fibrinolytic Agents;
Heparin;
Humans;
Lung;
Lupus Erythematosus, Systemic*;
Middle Aged;
Perfusion;
Pulmonary Embolism*;
Thorax;
Thromboembolism;
Thrombosis;
Tomography, X-Ray Computed;
Ventilation;
Warfarin
- From:Journal of Rheumatic Diseases
2015;22(2):106-110
- CountryRepublic of Korea
- Language:English
-
Abstract:
Patients with systemic lupus erythematosus (SLE) are at an increased risk of developing thromboses with antiphospholipid antibodies (aPL). The presence of aPL is related to an increased risk of thrombotic events. However, thromboembolic events can occur in SLE patients without aPL, and pulmonary emboli are rarely reported manifestations of SLE without aPL. Here, we report on a case of massive pulmonary embolism in a 58-year-old woman with aPL-negative SLE. She presented with chest pain and dyspnea, and chest computed tomography (CT) and lung perfusion ventilation scans showed pulmonary thromboembolism. She was administered thrombolytic agents, heparin, and warfarin. Two months later, no remarkable residual thromboembolism was observed on chest CT.
